CDA Foundation

Currently, the Foundation is focused on the global hepatitis b & c elimination. Our work has led to free access to hepatitis screening and treatment to over 1.6 billion people globally. In addition, we have helped over 130 countries quantify the burden of viral hepatitis and develop their national viral hepatitis elimination programs. In 2023, we supported the screening of 10,000 people in kazakhstan for hepatitis b and c and linking anyone found positive to care and treatment. In uganda, our program screened more than 20,000 pregnant women for hepatitis b, birth dose and three dose vaccination of all infants, and treatment of all high viral load pregnant women to reduce mother to child transmission. In pakistan, we conducted provincial analyses for hepatitis c burden and economic impact of a national elimination strategy. This work led to the prime minister's program which provides more than $200 million to provide free screening, lab tests and treatment for hcv infections.

We convened a meeting in london to discuss innovative financing for elimination of hepatitis. The meeting had 22 attendees from global health organizations (global fund, pharmaccess, clinton health initiative), national governments (viet nam, malaysia), develop bank (world bank), and suppliers (indian generic companies,diagnostic companies, originators). The suppliers paid for most of their own travel but we reimbursed flights (coach class), hotel and transportation for the others. We also paid for the meeting room and meals.